Use of Continuous Wound Infusion of Bupivacaine for Analgesia Following Axillary Clearance Surgery
NCT01314144
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
42
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Interventions
DRUG:
Bupivacaine
Sponsor
Cork University Hospital